Sulfocamphocaine-Darnitsa belongs to the group of analeptics. The mechanism of action of the medicine is the central nervous system excitation, primarily the centers of the medulla oblongata, both directly and through the carotid sinus.
Acute and chronic respiratory failure; acute heart failure in geriatric patients; respiratory depression in pneumonia and other infectious diseases; cardiogenic and anaphylactic shock; alcohol intoxication, mild forms of intoxication with hypnotics.
Sulfocamphocaine-Darnitsa should be prescribed for subcutaneous, intramuscular or intravenous (slow, push or drip) administration in adults in the single dose of 2 ml. 0.9 % sodium chloride solution should be used for dilution. If needed, the medicine can be used 2–3 times per day. The maximum daily dose for adults is 12 ml.